2211 Stock Overview
Universal Health International Group Holding Limited, an investment holding company, distributes and retails drugs, healthcare products, and other pharmaceutical products in the northeastern region of the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Universal Health International Group Holding Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.043 |
| 52 Week High | HK$0.20 |
| 52 Week Low | HK$0.041 |
| Beta | -0.14 |
| 1 Month Change | -29.51% |
| 3 Month Change | -51.69% |
| 1 Year Change | -70.34% |
| 3 Year Change | -82.80% |
| 5 Year Change | -96.26% |
| Change since IPO | -99.82% |
Recent News & Updates
Shareholder Returns
| 2211 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | -20.4% | 6.4% | 3.6% |
| 1Y | -70.3% | -28.6% | -10.1% |
Return vs Industry: 2211 underperformed the Hong Kong Healthcare industry which returned -29.2% over the past year.
Return vs Market: 2211 underperformed the Hong Kong Market which returned -10.9% over the past year.
Price Volatility
| 2211 volatility | |
|---|---|
| 2211 Average Weekly Movement | 15.7% |
| Healthcare Industry Average Movement | 6.5% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 14.6% |
| 10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 2211's share price has been volatile over the past 3 months.
Volatility Over Time: 2211's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 1,617 | Chuanfu Chu | www.uhighl.com |
Universal Health International Group Holding Limited, an investment holding company, distributes and retails drugs, healthcare products, and other pharmaceutical products in the northeastern region of the People’s Republic of China. Its product categories include Chinese patent medicines, chemical preparations, antibiotics and biochemical drugs, traditional Chinese medicine decoction pieces, biological products, protein assimilation preparations, peptide hormones, blood products, disinfection products, medical equipment, prepackaged foods, nutritional foods, health care products, stereotyped packaging cosmetics, and daily necessities, as well as family planning supplies, such as contraceptives and utensils; and dairy products, including infant formula milk powder. The company also provides storage services.
Universal Health International Group Holding Limited Fundamentals Summary
| 2211 fundamental statistics | |
|---|---|
| Market cap | HK$28.70m |
| Earnings (TTM) | -HK$88.74m |
| Revenue (TTM) | HK$1.18b |
0.0x
P/S Ratio-0.3x
P/E RatioIs 2211 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2211 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.09b |
| Cost of Revenue | CN¥914.97m |
| Gross Profit | CN¥176.43m |
| Other Expenses | CN¥258.52m |
| Earnings | -CN¥82.09m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.12 |
| Gross Margin | 16.17% |
| Net Profit Margin | -7.52% |
| Debt/Equity Ratio | 12.4% |
How did 2211 perform over the long term?
See historical performance and comparison